Injective Price Jumps 45%: Why INJ Could Be Heading Toward $8

Injective price has staged a sharp weekly rally, with INJ climbing nearly 45% from the $4 area toward $6 as buying momentum returns. The move has pushed the token above a key descending trendline and brought a major resistance zone back into focus. At the same time, Injective’s expanding institutional strategy and deflationary tokenomics are giving the rally a stronger narrative than a purely technical rebound. With INJ price now approaching $6, traders are watching whether the token can turn this recovery into a sustained breakout toward $7 and eventually $8.

INJ’s 45% Rally Has More Than Momentum Behind It

The latest repricing comes as Injective strengthens its position in the tokenized-finance market. On August 19, Injective Institutional Services became an SEC-registered transfer agent, giving the entity a regulated framework for maintaining securities ownership records and processing related transfers.

The development adds an important institutional layer to Injective’s broader tokenization strategy. While the registration does not represent SEC approval of INJ or an endorsement of the token, it strengthens the project’s ability to participate in regulated financial infrastructure and gives investors a more tangible catalyst behind the recent price recovery. INJ gained roughly 8% around the announcement before extending its advance, suggesting that traders have continued to price the development into the token rather than treating it as a one-day event.

Buyback Narrative Adds to the INJ Bull Case

Injective’s tokenomics is providing another layer to the current market narrative. Its Community BuyBack mechanism uses ecosystem revenue to purchase INJ, with the acquired tokens subsequently removed from circulation. Injective has said that more than 7 million INJ have been eliminated through its deflationary mechanisms.

A further buyback of more than $168,000 has also been reported for this week, although the figure has not been independently confirmed by Injective and should be treated as a reported allocation rather than a completed purchase.If ecosystem activity continues to generate revenue while market demand for INJ improves, the combination of purchases and permanent token removal could strengthen the supply-side backdrop for the asset.

INJ Price Analysis: $6 Breakout Could Open the Path to $8

INJ token has broken above its descending trendline, reclaimed the $5 region and accelerated toward $6, shifting the short-term structure in favor of buyers. The $6-$6.10 zone is now the immediate resistance. A sustained daily close above this region could confirm the breakout and expose $6.50, followed by the $7-$7.20 area. A successful move through those levels would bring the larger $7.50-$8 resistance zone into focus.

A nearly 45% weekly gain leaves INJ vulnerable to profit-taking, particularly if buyers fail to establish a sustained close above $6. The $5.40-$5.50 region has therefore become an important support zone. Holding above it during any pullback would keep the breakout structure intact, while a decisive loss could send INJ back toward $5 and potentially the $4.80 area.

What’s Next for Injective (INJ)?

The $8 target is becoming technically relevant, but INJ still needs to clear several layers of resistance before that move can develop. The immediate requirement is a decisive break above $6, followed by sustained buying through $6.50 and $7-$7.20. If those levels are reclaimed, the $7.50-$8 region would become the next major test.

The broader setup has also improved because the price recovery is now supported by both market structure and a clearer fundamental narrative around institutional tokenization and supply reduction. Still, after such a rapid move, consolidation would not necessarily invalidate the bullish outlook; the more important signal would be whether INJ can hold the newly reclaimed $5.40-$5.50 area.